News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
755,327 Results
Type
Article (44321)
Company Profile (323)
Press Release (710661)
Multimedia
Podcasts (112)
Webinars (25)
Section
Business (211025)
Career Advice (2161)
Deals (36382)
Drug Delivery (139)
Drug Development (82811)
Employer Resources (178)
FDA (16969)
Job Trends (15487)
News (355964)
Policy (33583)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2755)
Accelerated approval (48)
Adcomms (27)
Allergies (174)
Alliances (51587)
ALS (216)
Alzheimer's disease (1838)
Antibody-drug conjugate (ADC) (471)
Approvals (17365)
Artificial intelligence (720)
Autoimmune disease (301)
Automation (59)
Bankruptcy (363)
Best Places to Work (12038)
BIOSECURE Act (21)
Biosimilars (229)
Biotechnology (201)
Bladder cancer (197)
Brain cancer (74)
Breast cancer (774)
Cancer (5980)
Cardiovascular disease (486)
Career advice (1840)
Career pathing (44)
CAR-T (344)
CDC (61)
Celiac Disease (3)
Cell therapy (938)
Cervical cancer (47)
Clinical research (71928)
Collaboration (2197)
Company closure (5)
Compensation (1422)
Complete response letters (82)
COVID-19 (2805)
CRISPR (115)
C-suite (1202)
Cystic fibrosis (152)
Data (8068)
Decentralized trials (3)
Denatured (44)
Depression (168)
Dermatology (88)
Diabetes (594)
Diagnostics (7195)
Digital health (58)
Diversity (12)
Diversity, equity & inclusion (48)
Drug discovery (344)
Drug pricing (208)
Drug shortages (32)
Duchenne muscular dystrophy (291)
Earnings (93817)
Editorial (68)
Employer branding (21)
Employer resources (157)
Events (124613)
Executive appointments (1136)
FDA (20819)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1814)
Gene editing (245)
Generative AI (62)
Gene therapy (758)
GLP-1 (1083)
Government (4884)
Grass and pollen (7)
Guidances (411)
Healthcare (19823)
HIV (82)
Huntington's disease (56)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (98)
Immunology and inflammation (295)
Immuno-oncology (95)
Indications (197)
Infectious disease (3163)
Inflammatory bowel disease (225)
Inflation Reduction Act (15)
Influenza (140)
Intellectual property (300)
Interviews (339)
IPO (16998)
IRA (51)
Job creations (3766)
Job search strategy (1530)
JPM (65)
Kidney cancer (19)
Labor market (103)
Layoffs (585)
Leadership (44)
Legal (8130)
Liver cancer (103)
Longevity (32)
Lung cancer (779)
Lymphoma (432)
Machine learning (61)
Management (61)
Manufacturing (1095)
MASH (191)
Medical device (14581)
Medtech (14712)
Mergers & acquisitions (20659)
Metabolic disorders (1526)
mRNA (219)
Multiple sclerosis (189)
NASH (17)
Neurodegenerative disease (433)
Neuropsychiatric disorders (106)
Neuroscience (3387)
Neurotech (1)
NextGen: Class of 2026 (6794)
Non-profit (4783)
Now hiring (78)
Obesity (715)
Opinion (308)
Ovarian cancer (226)
Pain (264)
Pancreatic cancer (311)
Parkinson's disease (374)
Partnered (35)
Patents (613)
Patient recruitment (693)
Peanut (63)
People (61768)
Pharmaceutical (69)
Pharmacy benefit managers (32)
Phase 1 (22471)
Phase 2 (31673)
Phase 3 (23513)
Pipeline (8995)
Policy (329)
Postmarket research (2612)
Preclinical (9575)
Press Release (70)
Prostate cancer (311)
Psychedelics (54)
Radiopharmaceuticals (343)
Rare diseases (1112)
Real estate (6228)
Recruiting (70)
Regulatory (26093)
Reports (58)
Research institute (2550)
Resumes & cover letters (365)
Rett syndrome (39)
RNA editing (23)
RSV (94)
Schizophrenia (179)
Series A (302)
Series B (220)
Service/supplier (15)
Sickle cell disease (118)
Special edition (27)
Spinal muscular atrophy (170)
Sponsored (50)
Startups (3817)
State (2)
Stomach cancer (18)
Supply chain (132)
Tariffs (92)
The Weekly (66)
Vaccines (1134)
Venture capital (112)
Weight loss (460)
Women's health (131)
Worklife (22)
Date
Today (96)
Last 7 days (678)
Last 30 days (3614)
Last 365 days (31078)
2026 (13309)
2025 (31177)
2024 (36366)
2023 (41252)
2022 (52373)
2021 (56966)
2020 (55474)
2019 (48481)
2018 (36561)
2017 (33311)
2016 (32894)
2015 (39050)
2014 (32540)
2013 (27527)
2012 (29687)
2011 (30356)
2010 (28354)
Location
Africa (799)
Alabama (96)
Alaska (7)
Arizona (360)
Arkansas (16)
Asia (41885)
Australia (6851)
California (13587)
Canada (3838)
China (1421)
Colorado (580)
Connecticut (599)
Delaware (419)
Europe (92420)
Florida (2029)
Georgia (449)
Hawaii (3)
Idaho (64)
Illinois (1104)
India (95)
Indiana (617)
Iowa (24)
Japan (554)
Kansas (136)
Kentucky (51)
Louisiana (44)
Maine (76)
Maryland (1618)
Massachusetts (9848)
Michigan (385)
Minnesota (752)
Mississippi (7)
Missouri (157)
Montana (36)
Nebraska (29)
Nevada (149)
New Hampshire (88)
New Jersey (3628)
New Mexico (32)
New York (3590)
North Carolina (1790)
North Dakota (11)
Northern California (6789)
Ohio (406)
Oklahoma (26)
Oregon (43)
Pennsylvania (2723)
Puerto Rico (30)
Rhode Island (51)
South America (1169)
South Carolina (88)
South Dakota (2)
Southern California (5375)
Tennessee (218)
Texas (2182)
United States (48364)
Utah (411)
Vermont (1)
Virginia (333)
Washington D.C. (84)
Washington State (1085)
West Virginia (4)
Wisconsin (145)
Wyoming (2)
755,327 Results for "young innovations inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quantitative Biosciences Institute Appoints John A.T. Young, Ph.D., as Chief Strategy Officer
May 12, 2026
·
3 min read
Press Releases
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
April 24, 2026
·
8 min read
Press Releases
Press Release: Sanofi’s Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
April 22, 2026
·
8 min read
Press Releases
Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
April 23, 2026
·
27 min read
Press Releases
Brain Cancer Canada Awards The Dwayne Andrews Glioblastoma Research Grant to Tackle One of the Most Aggressive Brain Tumours and Unlock Immunotherapy Breakthroughs for Young Patients
May 21, 2026
·
4 min read
Press Releases
Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)
April 13, 2026
·
27 min read
Press Releases
Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Science, and Blood Cancer Treatment
March 11, 2026
·
10 min read
Press Releases
Terray Therapeutics Expands Board of Directors with Appointment of Biotechnology Leader Wendy Young, Ph.D.
Dr. Young brings more than 30 years of drug discovery leadership and expertise, as Terray’s AI-driven internal and partnered programs continue to accelerate toward patients in need
September 23, 2025
·
2 min read
Press Releases
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
April 23, 2026
·
18 min read
Opinion
Biotech can’t continue to innovate under strain of Big Pharma market pressures
Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a discovery system built around scientific uncertainty. Structural changes are needed to sustain the sector’s strategic innovation.
May 19, 2026
·
5 min read
·
Jeremy Levin
1 of 75,533
Next
